21,366 Shares in Privia Health Group, Inc. (NASDAQ:PRVA) Bought by EntryPoint Capital LLC

EntryPoint Capital LLC bought a new stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 21,366 shares of the company’s stock, valued at approximately $418,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Advantage Alpha Capital Partners LP purchased a new stake in Privia Health Group during the fourth quarter valued at about $2,253,000. LPL Financial LLC acquired a new position in Privia Health Group in the 4th quarter worth approximately $199,000. KLP Kapitalforvaltning AS purchased a new position in Privia Health Group during the 4th quarter worth approximately $383,000. Sei Investments Co. grew its position in Privia Health Group by 26.2% during the 4th quarter. Sei Investments Co. now owns 573,635 shares of the company’s stock worth $11,215,000 after purchasing an additional 119,052 shares in the last quarter. Finally, Corient Private Wealth LLC acquired a new stake in Privia Health Group during the 4th quarter valued at $1,345,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Stock Performance

PRVA opened at $22.75 on Wednesday. The company has a market cap of $2.74 billion, a PE ratio of 227.52, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. The stock has a 50-day moving average of $23.75 and a 200-day moving average of $21.11. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $26.04.

Wall Street Analysts Forecast Growth

PRVA has been the topic of a number of research analyst reports. Stephens reiterated an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a report on Thursday, January 2nd. JPMorgan Chase & Co. lifted their target price on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday, November 29th. Piper Sandler increased their price target on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a research report on Friday, February 28th. Macquarie assumed coverage on shares of Privia Health Group in a report on Monday, December 16th. They set an “outperform” rating and a $25.00 price target for the company. Finally, JMP Securities set a $29.00 price objective on shares of Privia Health Group in a research note on Friday, February 28th. One analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, Privia Health Group has a consensus rating of “Buy” and an average target price of $26.67.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.